Nothing Special   »   [go: up one dir, main page]

DK0637956T3 - Anvendelse af remacemid til behandling af Parkinsonˆs sygdom - Google Patents

Anvendelse af remacemid til behandling af Parkinsonˆs sygdom

Info

Publication number
DK0637956T3
DK0637956T3 DK93911903T DK93911903T DK0637956T3 DK 0637956 T3 DK0637956 T3 DK 0637956T3 DK 93911903 T DK93911903 T DK 93911903T DK 93911903 T DK93911903 T DK 93911903T DK 0637956 T3 DK0637956 T3 DK 0637956T3
Authority
DK
Denmark
Prior art keywords
remacemide
parkinson
disease
treatment
conjuction
Prior art date
Application number
DK93911903T
Other languages
English (en)
Inventor
Peter Chasewood House Johnson
Barry Ernest Watkins
Eric William Harris
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of DK0637956T3 publication Critical patent/DK0637956T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK93911903T 1992-05-02 1993-04-30 Anvendelse af remacemid til behandling af Parkinsonˆs sygdom DK0637956T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929209599A GB9209599D0 (en) 1992-05-02 1992-05-02 Novel therapy for the treatment of parkinsons disease
PCT/GB1993/000908 WO1993021910A1 (en) 1992-05-02 1993-04-30 Use of remacemide for the treatment of parkinson's disease

Publications (1)

Publication Number Publication Date
DK0637956T3 true DK0637956T3 (da) 1999-11-22

Family

ID=10714969

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93911903T DK0637956T3 (da) 1992-05-02 1993-04-30 Anvendelse af remacemid til behandling af Parkinsonˆs sygdom

Country Status (16)

Country Link
EP (1) EP0637956B1 (da)
JP (1) JP3542801B2 (da)
KR (1) KR950701216A (da)
AT (1) ATE181669T1 (da)
CA (1) CA2134783C (da)
DE (1) DE69325512T2 (da)
DK (1) DK0637956T3 (da)
ES (1) ES2135476T3 (da)
GB (1) GB9209599D0 (da)
GR (1) GR3031320T3 (da)
HU (1) HU211305A9 (da)
IL (1) IL105569A (da)
NZ (2) NZ299042A (da)
SG (1) SG49202A1 (da)
WO (1) WO1993021910A1 (da)
ZA (1) ZA933086B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025369A (en) * 1996-05-03 2000-02-15 The Board Of Regents Of The University Nebraska N-methyl-D-aspartate (NMDA) receptor blockers for the prevention of atherosclerosis
CA2477088A1 (en) 2002-02-22 2003-10-02 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
WO2008095221A1 (en) 2007-02-07 2008-08-14 Gosforth Centre (Holdings) Pty Ltd Treatment of adhd
AU2009279372A1 (en) 2008-08-06 2010-02-11 Gosforth Centre (Holdings) Pty Ltd Compositions and methods for treating psychiatric disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA908490B (en) * 1989-10-27 1991-07-31 Fisons Corp Use of arylalkylamides in the treatment of neurodegenerative diseases
DE3940410A1 (de) * 1989-12-04 1991-06-06 Schering Ag Neue verwendung von nmda-rezeptor-antagonisten

Also Published As

Publication number Publication date
HU211305A9 (en) 1995-11-28
WO1993021910A1 (en) 1993-11-11
NZ252728A (en) 1996-11-26
IL105569A0 (en) 1993-08-18
DE69325512D1 (de) 1999-08-05
ZA933086B (en) 1993-11-01
DE69325512T2 (de) 1999-12-16
JP3542801B2 (ja) 2004-07-14
ATE181669T1 (de) 1999-07-15
CA2134783A1 (en) 1993-11-11
SG49202A1 (en) 1998-05-18
JPH07506105A (ja) 1995-07-06
IL105569A (en) 1997-11-20
GR3031320T3 (en) 1999-12-31
ES2135476T3 (es) 1999-11-01
EP0637956B1 (en) 1999-06-30
CA2134783C (en) 2002-08-13
GB9209599D0 (en) 1992-06-17
NZ299042A (en) 2000-07-28
EP0637956A1 (en) 1995-02-15
KR950701216A (ko) 1995-03-23

Similar Documents

Publication Publication Date Title
PT100199A (pt) Combinacao antiviral de nucleosidos e processo para a sua preparacao
CY2009018I1 (el) Φαρμακευτικη συνθεση περιλαμβανουσα πιογλιταζονη και γλιμεπιριδη για χρηση στην θεραπεια του διαβητη
ATE131730T1 (de) Nukleosidanalogen enthaltende antiviren- zubereitungen
NO952309L (no) Anvendelse av riluzol ved behandling av Parkinsons sykdom og Parkinsonske syndromer
RU96116802A (ru) Перевязочный материал
ITRM910002A0 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
FR2735475B1 (fr) Derives de n-((1,4-diazabicyclo(2.2.2)oct-2-yl)methyl) benzamide, leur preparation et leur application en therapeutique
DK0637956T3 (da) Anvendelse af remacemid til behandling af Parkinsonˆs sygdom
NO302170B1 (no) Enantiomerisk 1-fenyl-2-(2-pyridinyl)etylamin, farmasöytisk formulering og anvendelse derav
ITMI910658A0 (it) N-(4,5-diidrossi-e 4,5,8-triidrossi-9,10-diidro-9,10-diosso-2- antracen-il)carbonil) amminoacidi utilizzabili nella terapia delle affezioni osteoarticolari
NO944809D0 (no) Biologisk aktive ureidoderivater som er nyttig i behandling av lentivirus-indusert sykdom
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
FR2818147B1 (fr) Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine
ITMI940030A0 (it) Compressa farmaceutica ad eleavata e rapida disponibilita' del principio attivo in essa veicolato
RU96118559A (ru) Лекарственное средство
ITBO930460A0 (it) Procedimento per preparare forme farmaceutiche a rilascio controllato del principio attivo e le forme farmaceutiche cosi' ottenute.
TH14332EX (th) อนุพันธ์ของอาร์จีนีน
FR2700115B1 (fr) Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
ITBO920455A1 (it) Procedimento per preparare forme farmaceutiche a rilascio controllato ritardato del principio attivo e le forme farmaceutiche cosi' ottenute.
IT1275987B1 (it) Composizione farmaceutica attiva nella cura di affezioni dermatologiche
IT9022457A0 (it) Composizione farmaceutica ad attivita' antiemorroidale e sua utilizzazione nella preparazione di forme farmaceutiche appropriate
ITMI910083A1 (it) Composizione farmaceutica ad attivita' antiemorroidale e sua utilizzazione nella preparazione di forme farmaceutiche appropriate
ITCA950008A0 (it) Impiego di combinaqzioni di analoghi di nucleosidi nella terapia delleinfezioni dell'aids.
TH14332A (th) อนุพันธ์ของอาร์จีนีน
ITDP920008A1 (it) Ustion-guariflash/ prodotto terapeutico per ustioni e piaghe infette, abrasioni, irritazioni cutanee, escoriazioni, senza controinicazioni,per uso esterno. farmaco di nuovissima invenzione, inesistente in commercio, tanto in italia che all'estero.